Bacterial polyphosphates induce CXCL4 and synergize with complement anaphylatoxin C5a in lung injury
Copyright © 2022 Roewe, Walachowski, Sharma, Berthiaume, Reinhardt and Bosmann..
Polyphosphates are linear polymers of inorganic phosphates that exist in all living cells and serve pleiotropic functions. Bacteria produce long-chain polyphosphates, which can interfere with host defense to infection. In contrast, short-chain polyphosphates are released from platelet dense granules and bind to the chemokine CXCL4. Here, we report that long-chain polyphosphates induced the release of CXCL4 from mouse bone marrow-derived macrophages and peritoneal macrophages in a dose-/time-dependent fashion resulting from an induction of CXCL4 mRNA. This polyphosphate effect was lost after pre-incubation with recombinant exopolyphosphatase (PPX) Fc fusion protein, demonstrating the potency of long chains over monophosphates and ambient cations. In detail, polyphosphate chains >70 inorganic phosphate residues were required to reliably induce CXCL4. Polyphosphates acted independently of the purinergic P2Y1 receptor and the MyD88/TRIF adaptors of Toll-like receptors. On the other hand, polyphosphates augmented LPS/MyD88-induced CXCL4 release, which was explained by intracellular signaling convergence on PI3K/Akt. Polyphosphates induced Akt phosphorylation at threonine-308. Pharmacologic blockade of PI3K (wortmannin, LY294002) antagonized polyphosphate-induced CXCL4 release from macrophages. Intratracheal polyphosphate administration to C57BL/6J mice caused histologic signs of lung injury, disruption of the endothelial-epithelial barrier, influx of Ly6G+ polymorphonuclear neutrophils, depletion of CD11c+SiglecF+ alveolar macrophages, and release of CXCL4. Long-chain polyphosphates synergized with the complement anaphylatoxin, C5a, which was partly explained by upregulation of C5aR1 on myeloid cells. C5aR1-/- mice were protected from polyphosphate-induced lung injury. C5a generation occurred in the lungs and bronchoalveolar lavage fluid (BALF) of polyphosphate-treated C57BL/6J mice. In conclusion, we demonstrate that polyphosphates govern immunomodulation in macrophages and promote acute lung injury.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
---|---|
Enthalten in: |
Frontiers in immunology - 13(2022) vom: 14., Seite 980733 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Roewe, Julian [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 22.11.2022 Date Revised 09.12.2022 published: Electronic-eCollection Citation Status MEDLINE |
---|
doi: |
10.3389/fimmu.2022.980733 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM349188955 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM349188955 | ||
003 | DE-627 | ||
005 | 20231226205603.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3389/fimmu.2022.980733 |2 doi | |
028 | 5 | 2 | |a pubmed24n1163.xml |
035 | |a (DE-627)NLM349188955 | ||
035 | |a (NLM)36405694 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Roewe, Julian |e verfasserin |4 aut | |
245 | 1 | 0 | |a Bacterial polyphosphates induce CXCL4 and synergize with complement anaphylatoxin C5a in lung injury |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 22.11.2022 | ||
500 | |a Date Revised 09.12.2022 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2022 Roewe, Walachowski, Sharma, Berthiaume, Reinhardt and Bosmann. | ||
520 | |a Polyphosphates are linear polymers of inorganic phosphates that exist in all living cells and serve pleiotropic functions. Bacteria produce long-chain polyphosphates, which can interfere with host defense to infection. In contrast, short-chain polyphosphates are released from platelet dense granules and bind to the chemokine CXCL4. Here, we report that long-chain polyphosphates induced the release of CXCL4 from mouse bone marrow-derived macrophages and peritoneal macrophages in a dose-/time-dependent fashion resulting from an induction of CXCL4 mRNA. This polyphosphate effect was lost after pre-incubation with recombinant exopolyphosphatase (PPX) Fc fusion protein, demonstrating the potency of long chains over monophosphates and ambient cations. In detail, polyphosphate chains >70 inorganic phosphate residues were required to reliably induce CXCL4. Polyphosphates acted independently of the purinergic P2Y1 receptor and the MyD88/TRIF adaptors of Toll-like receptors. On the other hand, polyphosphates augmented LPS/MyD88-induced CXCL4 release, which was explained by intracellular signaling convergence on PI3K/Akt. Polyphosphates induced Akt phosphorylation at threonine-308. Pharmacologic blockade of PI3K (wortmannin, LY294002) antagonized polyphosphate-induced CXCL4 release from macrophages. Intratracheal polyphosphate administration to C57BL/6J mice caused histologic signs of lung injury, disruption of the endothelial-epithelial barrier, influx of Ly6G+ polymorphonuclear neutrophils, depletion of CD11c+SiglecF+ alveolar macrophages, and release of CXCL4. Long-chain polyphosphates synergized with the complement anaphylatoxin, C5a, which was partly explained by upregulation of C5aR1 on myeloid cells. C5aR1-/- mice were protected from polyphosphate-induced lung injury. C5a generation occurred in the lungs and bronchoalveolar lavage fluid (BALF) of polyphosphate-treated C57BL/6J mice. In conclusion, we demonstrate that polyphosphates govern immunomodulation in macrophages and promote acute lung injury | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a acute respiratory distress syndrome | |
650 | 4 | |a immunology | |
650 | 4 | |a infection | |
650 | 4 | |a innate immunity | |
650 | 4 | |a platelet factor 4 | |
650 | 4 | |a sepsis | |
650 | 7 | |a Complement C5a |2 NLM | |
650 | 7 | |a 80295-54-1 |2 NLM | |
650 | 7 | |a Anaphylatoxins |2 NLM | |
650 | 7 | |a Platelet Factor 4 |2 NLM | |
650 | 7 | |a 37270-94-3 |2 NLM | |
650 | 7 | |a Polyphosphates |2 NLM | |
650 | 7 | |a Proto-Oncogene Proteins c-akt |2 NLM | |
650 | 7 | |a EC 2.7.11.1 |2 NLM | |
650 | 7 | |a Phosphatidylinositol 3-Kinases |2 NLM | |
650 | 7 | |a EC 2.7.1.- |2 NLM | |
650 | 7 | |a Myeloid Differentiation Factor 88 |2 NLM | |
650 | 7 | |a Immunologic Factors |2 NLM | |
700 | 1 | |a Walachowski, Sarah |e verfasserin |4 aut | |
700 | 1 | |a Sharma, Arjun |e verfasserin |4 aut | |
700 | 1 | |a Berthiaume, Kayleigh A |e verfasserin |4 aut | |
700 | 1 | |a Reinhardt, Christoph |e verfasserin |4 aut | |
700 | 1 | |a Bosmann, Markus |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Frontiers in immunology |d 2010 |g 13(2022) vom: 14., Seite 980733 |w (DE-627)NLM215811453 |x 1664-3224 |7 nnns |
773 | 1 | 8 | |g volume:13 |g year:2022 |g day:14 |g pages:980733 |
856 | 4 | 0 | |u http://dx.doi.org/10.3389/fimmu.2022.980733 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 13 |j 2022 |b 14 |h 980733 |